Viewing Study NCT04911660


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2026-03-11 @ 5:24 PM
Study NCT ID: NCT04911660
Status: COMPLETED
Last Update Posted: 2023-05-12
First Post: 2021-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Impact of the SGLT2 Inhibitor Empagliflozin on Urinary Supersaturations in Kidney Stone Formers
Sponsor: Insel Gruppe AG, University Hospital Bern
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Kidney Stone View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Kidney stones View
None Empagliflozin View
None Supersaturation View